Low tidal volume ventilation during cardiopulmonary bypass reduces postoperative chemokine serum concentrations

Thorac Cardiovasc Surg. 2014 Dec;62(8):677-82. doi: 10.1055/s-0034-1387824. Epub 2014 Dec 15.

Abstract

Background: Open-heart surgery with cardiopulmonary bypass (CPB) is associated with a generalized immune response and postoperative lung dysfunction. Chemokines are involved in the pathogenesis of postoperative lung dysfunction. We investigated whether continued mechanical ventilation during CPB has an impact on chemokine serum concentrations.

Methods: A total of 30 patients undergoing coronary artery bypass graft operation were randomized to either continuous ventilated group (n=15) or nonventilated group (n=15). Blood samples were drawn at the beginning and at the end of surgery and on the 5 consecutive days. Serum CCL2, CCL4, and CCL20 concentrations were measured and given as mean ± standard deviation.

Results: Chemokine concentrations were elevated at the end of surgery in both groups. CCL2 and CCL4 levels returned to baseline on postoperative day (POD)-1 in the ventilation group and stayed elevated in the nonventilation group. CCL4 serum levels were significantly lower in ventilated-group patients on POD-1 (10.9 [39.0] vs. 153.2 [168.1]; p=0.005), POD-2 (16.8 [36.8] vs. 147.9 [165.4]; p=0.019), POD-3 (14.2 [24.0] vs. 97.9 [87.1]; p=0.005), and POD-5 (6.5 [25.0] vs. 33.6 [38.4]; p=0.045).

Conclusion: Continued mechanical ventilation during CPB results in reduced CCL4 concentrations on POD-1 to -5.

Trial registration: ClinicalTrials.gov NCT01627756.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Austria
  • Biomarkers / blood
  • Cardiopulmonary Bypass / adverse effects*
  • Chemokine CCL2 / blood
  • Chemokine CCL20 / blood
  • Chemokine CCL4 / blood
  • Chemokines / blood*
  • Coronary Artery Bypass / adverse effects*
  • Down-Regulation
  • Female
  • Humans
  • Male
  • Middle Aged
  • Respiration, Artificial / methods*
  • Systemic Inflammatory Response Syndrome / blood*
  • Systemic Inflammatory Response Syndrome / diagnosis
  • Systemic Inflammatory Response Syndrome / etiology
  • Tidal Volume*
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers
  • CCL2 protein, human
  • CCL20 protein, human
  • CCL4 protein, human
  • Chemokine CCL2
  • Chemokine CCL20
  • Chemokine CCL4
  • Chemokines

Associated data

  • ClinicalTrials.gov/NCT01627756